BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30465163)

  • 21. Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy.
    Selvakumaran M; Amaravadi RK; Vasilevskaya IA; O'Dwyer PJ
    Clin Cancer Res; 2013 Jun; 19(11):2995-3007. PubMed ID: 23461901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
    Ilvesaro JM; Merrell MA; Li L; Wakchoure S; Graves D; Brooks S; Rahko E; Jukkola-Vuorinen A; Vuopala KS; Harris KW; Selander KS
    Mol Cancer Res; 2008 Oct; 6(10):1534-43. PubMed ID: 18922969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomeric G-quadruplex-forming DNA fragments induce TLR9-mediated and LL-37-regulated invasion in breast cancer cells in vitro.
    Tuomela JM; Sandholm JA; Kaakinen M; Hayden KL; Haapasaari KM; Jukkola-Vuorinen A; Kauppila JH; Lehenkari PP; Harris KW; Graves DE; Selander KS
    Breast Cancer Res Treat; 2016 Jan; 155(2):261-71. PubMed ID: 26780557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts.
    Damiano V; Caputo R; Garofalo S; Bianco R; Rosa R; Merola G; Gelardi T; Racioppi L; Fontanini G; De Placido S; Kandimalla ER; Agrawal S; Ciardiello F; Tortora G
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12468-73. PubMed ID: 17636117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocyte nuclear factor 4α suppresses the aggravation of colon carcinoma.
    Yao HS; Wang J; Zhang XP; Wang LZ; Wang Y; Li XX; Jin KZ; Hu ZQ; Wang WJ
    Mol Carcinog; 2016 May; 55(5):458-72. PubMed ID: 25808746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells.
    Li J; Hou N; Faried A; Tsutsumi S; Takeuchi T; Kuwano H
    Ann Surg Oncol; 2009 Mar; 16(3):761-71. PubMed ID: 19116755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The oncogenic role of NKAP in the growth and invasion of colon cancer cells.
    Shu W; Liu G; Dai Y; Feng A; Chen Z; Han J; Li X
    Oncol Rep; 2019 Nov; 42(5):2130-2138. PubMed ID: 31545474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SPINK1 contributes to proliferation and clonal formation of HT29 cells through Beclin1 associated enhanced autophagy.
    Hu NA; Zhang S; Jin A; Guo L; Qu Z; Wang J
    Oncol Res; 2022; 30(2):89-97. PubMed ID: 37305325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DK1 Induces Apoptosis via Mitochondria-Dependent Signaling Pathway in Human Colon Carcinoma Cell Lines In Vitro.
    Hussin Y; Aziz MNM; Che Rahim NF; Yeap SK; Mohamad NE; Masarudin MJ; Nordin N; Abd Rahman NMA; Yong CY; Akhtar MN; Zamrus SNH; Alitheen NB
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29641445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells.
    Moreira D; Zhang Q; Hossain DM; Nechaev S; Li H; Kowolik CM; D'Apuzzo M; Forman S; Jones J; Pal SK; Kortylewski M
    Oncotarget; 2015 Jul; 6(19):17302-13. PubMed ID: 26046794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel cycloartane triterpenoid from Cimicifuga induces apoptotic and autophagic cell death in human colon cancer HT-29 cells.
    Dai X; Liu J; Nian Y; Qiu MH; Luo Y; Zhang J
    Oncol Rep; 2017 Apr; 37(4):2079-2086. PubMed ID: 28260002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trichostatin A and sirtinol suppressed survivin expression through AMPK and p38MAPK in HT29 colon cancer cells.
    Hsu YF; Sheu JR; Lin CH; Yang DS; Hsiao G; Ou G; Chiu PT; Huang YH; Kuo WH; Hsu MJ
    Biochim Biophys Acta; 2012 Feb; 1820(2):104-15. PubMed ID: 22155142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abrus agglutinin stimulates BMP-2-dependent differentiation through autophagic degradation of β-catenin in colon cancer stem cells.
    Panda PK; Naik PP; Praharaj PP; Meher BR; Gupta PK; Verma RS; Maiti TK; Shanmugam MK; Chinnathambi A; Alharbi SA; Sethi G; Agarwal R; Bhutia SK
    Mol Carcinog; 2018 May; 57(5):664-677. PubMed ID: 29457276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of CD44v6 Enhances Chemosensitivity by Promoting Apoptosis and Inhibiting Autophagy in Colorectal Cancer HT29 Cells.
    Wang QX; Lv L; Ye DR; Sun YH; Pan XX; Bhandari A; Zhang XH; Wang OC; Liu HG
    Ann Clin Lab Sci; 2019 Sep; 49(4):481-487. PubMed ID: 31471337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PSF knockdown enhances apoptosis via downregulation of LC3B in human colon cancer cells.
    Tsukahara T; Matsuda Y; Haniu H
    Biomed Res Int; 2013; 2013():204973. PubMed ID: 24288667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter methylation of the DLC‑1 gene and its inhibitory effect on human colon cancer.
    Dai Z; Jin Y
    Oncol Rep; 2013 Sep; 30(3):1511-7. PubMed ID: 23783552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll-like receptor 9 agonist inhibits ERalpha-mediated transactivation by activating NF-kappaB in breast cancer cell lines.
    Qiu J; Wang X; Guo X; Zhao C; Wu X; Zhang Y
    Oncol Rep; 2009 Oct; 22(4):935-41. PubMed ID: 19724876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apigenin inhibits in vitro and in vivo tumorigenesis in cisplatin-resistant colon cancer cells by inducing autophagy, programmed cell death and targeting m-TOR/PI3K/Akt signalling pathway.
    Chen X; Xu H; Yu X; Wang X; Zhu X; Xu X
    J BUON; 2019; 24(2):488-493. PubMed ID: 31127995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. l-carnosine dipeptide overcomes acquired resistance to 5-fluorouracil in HT29 human colon cancer cells via downregulation of HIF1-alpha and induction of apoptosis.
    Iovine B; Guardia F; Irace C; Bevilacqua MA
    Biochimie; 2016 Aug; 127():196-204. PubMed ID: 27234614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental therapy for colon cancer: anti-cancer effects of TLR9 agonism, combination with other therapeutic modalities, and dependence upon p53.
    Rayburn ER; Wang W; Zhang R; Wang H
    Int J Oncol; 2007 Jun; 30(6):1511-9. PubMed ID: 17487373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.